Stay updated on T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial
Sign up to get notified when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.

Latest updates to the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page
- Check2 days agoChange DetectedThe page now displays Revision: v3.3.4 and no longer shows Revision: v3.3.3.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a comprehensive Locations section listing trial sites across the US and Canada (and included multiple provinces), reflecting expanded site availability. The previous location sublists and the HHS Vulnerability Disclosure link were removed or updated, accompanying a Revision: v3.3.3.SummaryDifference0.8%

- Check52 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2; no user-facing content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedA PubMed auto-fill note was added and the revision tag updated to v3.3.1, replacing the previous PubMed note and revision label.SummaryDifference0.0%

- Check66 days agoChange DetectedAdded two new recruitment sites for Tainan, Taiwan (70403 and 710) and updated existing entries from 'Tainan City' to 'Tainan, Taiwan' for the same codes. The government funding status notice was removed.SummaryDifference0.1%

- Check80 days agoChange DetectedNo meaningful differences observed between the two screenshots; the page content and structure appear unchanged.SummaryDifference0.1%

Stay in the know with updates to T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.